BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11781820)

  • 1. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase.
    Dorey K; Engen JR; Kretzschmar J; Wilm M; Neubauer G; Schindler T; Superti-Furga G
    Oncogene; 2001 Dec; 20(56):8075-84. PubMed ID: 11781820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases.
    Thaimattam R; Daga PR; Banerjee R; Iqbal J
    Bioorg Med Chem; 2005 Aug; 13(15):4704-12. PubMed ID: 15914012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.
    Mitra A; Radha V
    Oncogene; 2010 Aug; 29(32):4528-42. PubMed ID: 20581864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
    Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
    Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
    Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
    Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
    Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1.
    Plattner R; Irvin BJ; Guo S; Blackburn K; Kazlauskas A; Abraham RT; York JD; Pendergast AM
    Nat Cell Biol; 2003 Apr; 5(4):309-19. PubMed ID: 12652307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl tyrosine kinase regulates c-fos gene expression via phosphorylating RNA polymerase II.
    Jing Y; Song Z; Wang M; Tang W; Hao S; Zeng X
    Arch Biochem Biophys; 2005 May; 437(2):199-204. PubMed ID: 15850559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
    Cowan-Jacob SW; Fendrich G; Manley PW; Jahnke W; Fabbro D; Liebetanz J; Meyer T
    Structure; 2005 Jun; 13(6):861-71. PubMed ID: 15939018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase.
    Nagano K; Itagaki C; Izumi T; Nunomura K; Soda Y; Tani K; Takahashi N; Takenawa T; Isobe T
    Oncogene; 2006 Jan; 25(4):493-502. PubMed ID: 16158058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe.
    Walkenhorst J; Goga A; Witte ON; Superti-Furga G
    Oncogene; 1996 Apr; 12(7):1513-20. PubMed ID: 8622867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Abl and insulin receptor signalling.
    Genua M; Pandini G; Cassarino MF; Messina RL; Frasca F
    Vitam Horm; 2009; 80():77-105. PubMed ID: 19251035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.
    Schulte RJ; Sefton BM
    Biochemistry; 2003 Aug; 42(31):9424-30. PubMed ID: 12899629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Abl kinase is required for beta 2 integrin-mediated neutrophil adhesion.
    Cui L; Chen C; Xu T; Zhang J; Shang X; Luo J; Chen L; Ba X; Zeng X
    J Immunol; 2009 Mar; 182(5):3233-42. PubMed ID: 19234221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human c-Abl tyrosine kinase activity in Xenopus oocytes and acceleration of progesterone-induced G2/M transition by oncogenic forms.
    Dorey K; Barilá D; Gavin AC; Nebreda AR; Superti-Furga G
    Biol Chem; 1999 Feb; 380(2):223-30. PubMed ID: 10195429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.